NICE reveals new standards for digital techNICE has published new standards setting out the requirements needed to develop digital health technologies for the NHS Share XNICE reveals new standards for digital techhttps://pharmaphorum.com/news/nice-reveals-new-standards-for-digital-tech/
NHS lags best performers in cancer care – reportThe performance of NHS cancer services in England is lagging behind those of comparable countries, according to a Share XNHS lags best performers in cancer care – reporthttps://pharmaphorum.com/news/nhs-lags-best-performers-in-cancer-care-report/
New UK drug pricing deal promises faster medicines accessThe UK government has reached a new five-year medicines pricing deal with the pharma industry to replace the Share XNew UK drug pricing deal promises faster medicines accesshttps://pharmaphorum.com/news/new-uk-drug-pricing-deal-promises-faster-medicines-access/
Government challenges medical devices firms to improve NHSThe UK’s government is urging businesses to apply for a share of up to £1.5 million to support Share XGovernment challenges medical devices firms to improve NHShttps://pharmaphorum.com/news/government-challenges-medical-devices-firms-to-improve-nhs/
NHS long-term plan focuses on preventive health and genomicsHealth and social care secretary Matt Hancock today unveils his long-term NHS plan, which focuses on people taking Share XNHS long-term plan focuses on preventive health and genomicshttps://pharmaphorum.com/news/nhs-long-term-plan-focuses-on-preventive-health-and-genomics/
How the NHS got ahead of the curve with CAR-TThe UK’s pharma industry has welcomed the NHS’ fast adoption of the latest CAR-T cancer therapies. Richard Staines Share XHow the NHS got ahead of the curve with CAR-Thttps://pharmaphorum.com/views-analysis-oncology/nhs-got-ahead-curve-car-t/
UK opens doors to cannabis-based therapies via NHSMedical cannabis is available to certain patients across the UK for the first time from today. The groundbreaking Share XUK opens doors to cannabis-based therapies via NHShttps://pharmaphorum.com/news/medicinal-cannabis-legal-nhs/
Ahead of the curvePharma often criticises the NHS for failing to adopt the latest therapies, arguing that NICE’s technology appraisals can Share XAhead of the curvehttps://pharmaphorum.com/views-analysis-oncology/ahead-curve-car-t/
Pharma body agrees five-year deal to boost NHS innovationThe UK’s pharma trade body, the Association of the British Pharmaceutical Industry (ABPI), has signed a five-year partnership Share XPharma body agrees five-year deal to boost NHS innovationhttps://pharmaphorum.com/news/abpi-agrees-five-year-deal-to-boost-nhs-innovation/
